This double-blind randomized clinical trial will be conducted to assess the effect of Licorice on premenstrual symptoms. The study population comprise 84 female students having premenstrual symptoms according to PSST (Premenstrual Symptoms Screening Tool) questionnaire and satisfied the inclusion criteria. The participants will be randomly assigned into Licorice or placebo group. The participants in the intervention group will receive Licorice capsule while participants in the control group will receive placebo with the same dosage. The outcome measures in this study are premenstrual symptoms, as obtained through the PSST questionnaire before and during the intervention. At the end of the study, two premenstrual syndrome sign scores will be obtained for every participant (1 before intervention to recognize the eligible samples and after 2 cycle intervention).
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2015061722779N1
Registration date:2015-06-29, 1394/04/08
Registration timing:prospective
Last update:
Update count:0
Registration date
2015-06-29, 1394/04/08
Registrant information
Name
Maryam Farahmand
Name of organization / entity
Tehran University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 21 6642 1685
Email address
m-farahmand@razi.tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Tehran University of Medical Sciences
Expected recruitment start date
2016-02-04, 1394/11/15
Expected recruitment end date
2016-10-06, 1395/07/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The Study on the Effects of Licorice compared to placebo on severity of Pre Menstrual Syndrome (PMS) signs among college students
Public title
Effects of Licorice on premenstrual disturbances
Purpose
Screening
Inclusion/Exclusion criteria
Inclusion criteria: age 18-35 years; having regular menstrual cycles; experience of PMS symptoms; not smoking; alcohol or drug usage; willingness to participate in the study; completed a written informed consent.
Exclusion criteria: pregnancy; lactation; menstrual cycle irregularity; medical disease; hormonal method of contraception; developing tensions and severe psychological crisis within the past 6 months.